4.1 Article

A patient showing features of both SBBYSS and GPS supports the concept of a KAT6B-related disease spectrum, with mutations in mid-exon 18 possibly leading to combined phenotypes

Journal

EUROPEAN JOURNAL OF MEDICAL GENETICS
Volume 58, Issue 10, Pages 550-555

Publisher

ELSEVIER SCIENCE BV
DOI: 10.1016/j.ejmg.2015.09.004

Keywords

KAT6B; Genitopatellar syndrome; Say-Barber-Biesecker-Young-Simpson syndrome; Genotype-phenotype correlation

Funding

  1. programs of the Charles University in Prague [00064203, NT/14200, CZ.2.16/3.100/24022, NF-CZ11-PDP-3-003-2014, UNCE 20401, PRVOUK-P24/LF1/3, SVV-UK 260148/2015]
  2. BIOCEV - Biotechnology and Biomedicine Centre of the Academy of Sciences and Charles University from the European Regional Development Fund [CZ.1.05/1.1.00/02.0109]
  3. Ministry of Health of the Czech Republic [NT13116-4/2012]

Ask authors/readers for more resources

Genitopatellar syndrome (GPS) and Say-Barber-Biesecker-Young-Simpson syndrome (SBBYSS) are two distinct clinically overlapping syndromes caused by de novo heterozygous truncating mutations in the KAT6B gene encoding lysine acetyltransferase 6B, a part of the histone H3 acetyltransferase complex. We describe an 8-year-old girl with a KAT6B mutation and a combined GPS/SBBYSS phenotype. The comparison of this patient with 61 previously published cases with KAT6B mutations and GPS, SBBYSS or combined GPS/SBBYSS phenotypes allowed us to separate the KAT6B mutations into four groups according to their position in the gene (reflecting nonsense mediated RNA decay and protein domains) and their clinical outcome. We suggest that mutations in mid-exon 18 corresponding to the C-terminal end of the acidic (Asp/Glu-rich) domain of KAT6B may have more variable expressivity leading to GPS, SBBYSS or combined phenotypes, in contrast to defects in other regions of the gene which contribute more specifically to either GPS or SBBYSS. Notwithstanding the clinical overlap, our cluster analysis of phenotypes of all known patients with KAT6B mutations supports the existence of two clinical entities, GPS and SBBYSS, as poles within the KAT6B-related disease spectrum. The awareness of these phenomena is important for qualified genetic counselling of patients with KAT6B mutations. (C) 2015 Elsevier Masson SAS. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.1
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available